Vertex Pharmaceuticals Incorporated provides revenue guidance for the first quarter of 2018. For the quarter, the company that anticipate revenues will be impacted by higher gross-to-net revenue adjustments that experienced in the first quarter of each year and by channel inventory build that occurred in the fourth quarter of 2017.